Pacira Pharmaceuticals shares owned by Simplex Trading
Quarter-by-quarter ownership of Pacira Pharmaceuticals shares owned by Simplex Trading
from 13F filings
Historical chart of Simplex Trading investment in Pacira Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Pacira Pharmaceuticals held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Pacira Pharmaceuticals by Simplex Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $12k | 500 | 24.00 |
| 2025-06-30 | $9.0k | 400 | 22.50 |
| 2025-03-31 | $4.0k | 200 | 20.00 |
| 2024-12-31 | $446k | 24k | 18.82 |
| 2024-09-30 | $385k | 26k | 15.04 |
| 2024-06-30 | $145k | 5.1k | 28.43 |
| 2024-03-31 | $365k | 13k | 29.20 |
| 2023-12-31 | $84k | 2.5k | 33.60 |
| 2023-09-30 | $21k | 700 | 30.00 |
| 2023-03-31 | $16k | 400 | 40.00 |
| 2022-12-31 | $15k | 400 | 37.50 |
| 2022-03-31 | $564k | 7.4k | 76.22 |
| 2021-12-31 | $35k | 600 | 58.33 |
| 2021-09-30 | $35k | 600 | 58.33 |
| 2021-06-30 | $36k | 600 | 60.00 |
| 2021-03-31 | $217 | 31 | 7.00 |
| 2020-12-31 | $5 | 1 | 5.00 |
| 2020-06-30 | $167 | 32 | 5.22 |
| 2020-03-31 | $362 | 108 | 3.35 |
| 2019-12-31 | $49 | 11 | 4.45 |
| 2019-09-30 | $513 | 135 | 3.80 |
| 2019-06-30 | $86 | 20 | 4.30 |
| 2019-03-31 | $128 | 34 | 3.79 |
| 2018-12-31 | $4 | 1 | 4.00 |
| 2018-09-30 | $3.9k | 791 | 4.91 |
| 2018-06-30 | $887 | 277 | 3.20 |
| 2018-03-31 | $170k | 508 | 334.65 |
| 2017-12-31 | $33k | 187 | 176.47 |
| 2017-09-30 | $32k | 34 | 941.18 |
| 2017-06-30 | $3.0k | 32 | 93.75 |
| 2017-03-31 | $14k | 58 | 241.38 |
| 2016-12-31 | $83k | 116 | 715.52 |
| 2016-09-30 | $70k | 79 | 886.08 |
| 2016-06-30 | $199k | 150 | 1326.67 |
| 2016-03-31 | $51k | 56 | 910.71 |
| 2015-12-31 | $3.0k | 26 | 115.38 |
| 2015-09-30 | $181k | 79 | 2291.14 |
| 2015-06-30 | $27k | 62 | 435.48 |
| 2015-03-31 | $17k | 15 | 1133.33 |
| 2014-12-31 | $6.0k | 20 | 300.00 |
Top funds holding Pacira Pharmaceuticals
View all funds holding Pacira Pharmaceuticals